Today, the Asymmetric Universe includes 25 stocks I’ve covered in spotlight articles, and the list will continue to grow over time. 🌱 Being part of the universe does not guarantee an investment. Some stocks may never receive capital, while others can be purchased multiple times as opportunities emerge. 💰 How I Allocate New Capital I invest $500 in new capital every month. 📌 If the $S&P 500(.SPX)$ or $NASDAQ 100(NDX)$ falls 20% from its all-time high, monthly capital increases to $1,000. 📌 At a 30% decline, I’ll add $1,500. 📌 The allocation continues to increase as the broader market falls further. The idea is simple: put more capital to work when the market becomes more distressed. 🔄 🎯 How I Pick Stoc
I'm 30% invested in $TransMedics Group, Inc.(TMDX)$. It might look like an oversized position, but I think the risk is worth taking: • At $70, the stock was absurdly cheap, and the market overpunished it for its investment-heavy focus • Even after the recent rebound, the company still trades cheap relative to sector averages given its 20%+ growth rate • Q3 numbers are very likely to impress, with a strong acceleration in growth. Since the market isn't efficient and tends to focus on the short term, I expect the stock to keep climbing over the coming months • The medtech sector has suffered a lot lately, without much real justification. A lot of funds rotated into biotech, which now trades at clearly richer valuations. I expect capi
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
08-05
Quarterly Report
Form 10-Q - Quarterly report [Sections 13 or 15(d)]